ABOS
Acumen Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.27
-0.03 ▼ -0.91%
🌙 3월 13일 5:48 PM ET (한국 3/14 06:48)
$3.26
-0.01 ▼ -0.31%
| Index | - | P/E | - | EPS (ttm) | -2.21 | Insider Own | 23.48% | Shs Outstand | 0.06B | Perf Week | -1.21% |
| Market Cap | 0.20B | Forward P/E | - | EPS next Y | 19.51% | Insider Trans | -1.84% | Shs Float | 0.05B | Perf Month | 27.73% |
| Enterprise Value | 0.10B | PEG | - | EPS next Q | -0.45 | Inst Own | 50.81% | Short Float | 2.07% | Perf Quarter | 72.11% |
| Income | -0.13B | P/S | - | EPS this Y | -19.71% | Inst Trans | -0.17% | Short Ratio | 1.53 | Perf Half Y | 135.25% |
| Sales | 0.00B | P/B | 2.13 | EPS next 5Y | 5.22% | ROA | -65.18% | Short Interest | 0.96M | Perf YTD | 54.98% |
| Book/sh | 1.54 | P/C | 1.56 | EPS past 3/5Y | 11.81% -54.87% | ROE | -85.93% | 52W High | -6.44% ($3.49) | Perf Year | 168.03% |
| Cash/sh | 2.09 | P/FCF | - | Sales past 3/5Y | - | ROIC | -110.88% | 52W Low | 282.41% ($0.86) | Perf 3Y | -24.65% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -60.99% | Gross Margin | - | Volatility(W/M) | 9.86% 9.13% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.27 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.02 | EPS Q/Q | 11.85% | Profit Margin | - | RSI (14) | 64.25 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.02 | Sales Q/Q | - | SMA20 | 9.07% ($3) | Beta | 0.19 | Target Price | $7 |
| Payout | - | Debt/Eq | 0.33 | Earnings | 11000000 | SMA50 | 30.3% ($2.51) | Rel Volume | 0.63 | Prev Close | $3.3 |
| Employees | 61 | LT Debt/Eq | 0.29 | EPS/Sales Surpr. | 27.03% - | SMA200 | 79.1% ($1.83) | Avg Volume(3M) | 0.63M | Price | $3.27 |
| IPO | 2021/7/1 | Option/Short | Yes/Yes | Trades | 2734 | Volume | 393,590 | Change | -0.91% |
뉴스 로딩 중...